Clinicopathological Features and Outcomes of Endometrial Cancer: A single institution experience.

Autor: Burney IA; Women Health Program, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman., Al Ghafri S; Department of Surgery, The Royal Hospital, Muscat, Oman., Al Noumani J; Department of Medicine, The Royal Hospital, Muscat, Oman., Al Jabri A; Department of Radiation Oncology, The Royal Hospital, Muscat, Oman., Hasan AO; Women Health Program, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman., Bella S; Women Health Program, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman., Al-Sayegh H; Department of Research Laboratories, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman., Al Ajmi R; Pathology, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman., Al Kalbani M; Women Health Program, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.
Jazyk: angličtina
Zdroj: Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 May; Vol. 24 (2), pp. 203-208. Date of Electronic Publication: 2024 May 27.
DOI: 10.18295/squmj.3.2024.015
Abstrakt: Objectives: This study aimed to report the demographic features, clinical presentation, pathological types and long-term outcomes of patients diagnosed with endometrial cancer (EC) in Oman. EC is the sixth most common cancer in women worldwide and the fifth most common cancer in women in Oman. Survival outcomes of EC have not been reported previously from Oman.
Methods: This retrospective study was carried out on consecutive patients treated at the Sultan Qaboos University Hospital, Muscat, Oman, between 2008 and 2020. Survival was estimated using the Kaplan and Meier method.
Results: A total of 50 patients with EC were included. The median age was 61 years (range: 31-86 years), and 72% of the patients had type I histology. Most patients were diagnosed with stage IA and IB EC (49% and 20%, respectively), and the majority had grade 1 or 2 tumours (40% and 34%, respectively). Overall, the 5-year survival and 10-year survival rates were estimated to be 70% and 56%, respectively. Weight (>75 kg) and body mass index (>30 kg/m 2 ) were significantly associated with better survival. Tumour histology (type I versus type II or carcinosarcoma), grade (1 versus 2 versus 3) and stage (IA or IB versus II-IV) were associated with better overall survival ( P = 0.007, P <0.0001 and P <0.0003, respectively). Patients diagnosed with EC with co-morbidities, other than obesity, had inferior survival compared to those without co-morbidities.
Conclusion: Median age at presentation, histological sub-type, clinical stage and outcomes are comparable to the published literature. Almost two-thirds of the patients were obese. These data could be used as a benchmark for outcomes of EC in the region.
Competing Interests: CONFLICTS OF INTEREST: The authors declare no conflict of interest.
(© Copyright 2024, Sultan Qaboos University Medical Journal, All Rights Reserved.)
Databáze: MEDLINE
Externí odkaz: